We are on a mission to create better and safer therapeutics enabled by cryopreservation.
Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions for the cell therapy industry.
Our cryopreservation technology was developed by world-leading cryobiologist, Professor Allison Hubel, PhD, at the University of Minnesota and is optimized for each cell to deliver the highest cell viability, recovery, and functional performance.
Leadership Team
Christiaan Engstrom, MBA
CEO
- Former Founder & CEO at Cell Culture Company
- Former COO at Medical Advanced Pain Specialists (MAPS)
- Multiple successful exits in healthcare technologies
Allison Hubel, Ph.D.
CSO & Founder
- World-leading cryopreservation expert
- Professor, Mechanical Engineering – University of Minnesota
- Director, Biopreservation Core Resource – University of Minnesota
- President, Society for Cryobiology
Jeff Williams, Ph.D.
COO
- Former President – Lucigen
- Former President & CEO – Platypus Technologies
- Multiple successful exits in biotech
Bryan Poltilove, MBA
Board Chairman
- Operating Partner – Broad Oak Capital Partners
- Former Cell & Gene Therapy General Manager – Thermo Fisher
- Multiple cell and gene therapy tool investments, acquisitions, and exits
Sandy Williams, Ph.D.
Strategy Advisor
- Founder & President – Access Biomedical Solutions
- Biomedical engineering and marketing consulting for medtech and biotech
- Former Biologics Business Unit Manager, Bose Corporation
Jason Maidment, MBA
Financial Advisor
- Fractional CFO – JAM Services
- Senior Director Finance – UnitedHealth Group
- General Manager – Hanratty & Associates
Get the latest cryopreservation news, CryoChats™ info, and all the updates.
Evia Bio
Office
2001 6th St SE, Room 2-434
Minneapolis, MN 55455
© 2022 Evia Bio • Privacy Policy
